<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310983</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00140895</org_study_id>
    <nct_id>NCT03310983</nct_id>
  </id_info>
  <brief_title>Growth and Adiposity in Newborns: The Influence of Prenatal DHA Supplementation</brief_title>
  <acronym>ADORE-GAINS</acronym>
  <official_title>Growth and Adiposity in Newborns: The Influence of Prenatal DHA Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who
      took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to
      24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infant Fat Mass (FM)</measure>
    <time_frame>Change from Baseline to Month 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central Fat Mass</measure>
    <time_frame>Change from Baseline to Month 24</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pregnancy; Nutritional Diseases</condition>
  <arm_group>
    <arm_group_label>ADORE Participants</arm_group_label>
    <description>Participants enrolled in the ADORE study are invited to participate in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Docosahexaenoic acid</intervention_name>
    <description>The main study, ADORE, includes providing DHA to participants during pregnancy. No intervention is included as part of this study.</description>
    <arm_group_label>ADORE Participants</arm_group_label>
    <other_name>DHA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants are invited from those already participating in the parent study, ADORE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Participants for this study are invited from the parent study, ADORE. Eligibility listed
        reflects criteria for the ADORE study.

        Inclusion Criteria:

          -  Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA

          -  Available by telephone

        Exclusion Criteria:

          -  Expecting multiple infants

          -  Gestational age at baseline &lt;12 weeks or &gt;20 weeks

          -  Unable or unwilling to agree to consume capsules until delivery

          -  Unwilling to discontinue use of another prenatal supplement with DHA that contains â‰¥
             200 mg DHA

          -  Women with allergy to any component of DHA product (including algae), soybean oil or
             corn oil
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holly Hull, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beth Kerling, MS, RD</last_name>
    <phone>913-588-5743</phone>
    <email>ekerling@kumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicaltrials.gov/ct2/show/NCT02626299</url>
    <description>ADORE Clinicaltrials.gov Record - Parent Study</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2017</study_first_submitted>
  <study_first_submitted_qc>October 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fat mass</keyword>
  <keyword>Gestational weight gain</keyword>
  <keyword>Fetal adipose tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

